A review of cardiovascular outcomes in the treatment of people with type 2 diabetes. - Wikidata - wikimedia - TriplyDB

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

http://www.wikidata.org/entity/Q34726469

about

Electronic messaging intervention for management of cardiovascular risk factors in type 2 diabetes mellitus: a randomised controlled trial.The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL.Whole genome sequence analysis of the TALLYHO/Jng mouse.Detecting Heterogeneous Treatment Effects to Guide Personalized Blood Pressure Treatment: A Modeling Study of Randomized Clinical Trials.

P2860

Q33455535-415E8A55-BB28-4C84-9886-04640541BF7F Q33709306-1450D30E-9A71-47F9-9586-BCB53D3C4756 Q36190115-12C58221-18DB-4FAF-A176-DD44C5DF715E Q39038713-A88A8CE3-71E4-44FC-A6C2-F346093A23F6

P2860

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

http://www.wikidata.org/entity/Q34726469

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

@ast

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

@en

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

@nl

type

label

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

@ast

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

@en

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

@nl

prefLabel

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

@ast

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

@en

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

@nl

P1433

Q34726469-0294B497-649F-45D6-9A35-78E3DF1E7A29

P1476

Q34726469-DF8BAB74-A9BA-44A0-BC67-543E092244AE

P2093

Q34726469-4A19C94A-0C1D-4C9F-9E2F-DB14658084BB

Q34726469-8235B561-78B7-4A4A-AC4C-F86C84817905

P2860

Q34726469-06BED8A0-CE42-467B-BA42-0BAF6FBFA03B

Q34726469-1A59BDDB-BAF8-43BD-ABEB-DBCA0CDD590D

Q34726469-1CACE4A6-AFE4-487D-9314-88D87A4310E7

Q34726469-20BE5D75-817E-4255-915A-24E2986F5EAF

Q34726469-20FC53FD-9311-4D94-AB7E-84D5B97D0600

Q34726469-299DC4E4-7898-4224-8072-56708395DEB5

Q34726469-2D6A46C2-B5ED-4DBF-A2D6-C14CDED6F073

Q34726469-2E23018E-1333-4D17-9C02-8B380011A446

Q34726469-3E21A421-24A2-4444-AAC6-C1605D9E221D

Q34726469-42A88F2C-A34C-463C-BD62-414B27AF709A

P2888

Q34726469-FE27A9AE-7ACB-451A-8370-06FC8A01ED4D

P304

Q34726469-F00F2305-13D1-41D0-9D14-62765603F9ED

P31

Q34726469-78C7C3D1-35A5-4C52-9A1D-147341386DB6

P356

Q34726469-8A2BECE4-2CC5-4DDE-9423-7D88E665EBE4

P433

Q34726469-C70CDD9F-68E6-400E-9E3D-B3F45599A72E

P478

Q34726469-879BD646-0479-4BF8-9CBB-D3E95D40801F

P577

Q34726469-661F60AF-104B-4FFC-998E-490D025C0E68

P5875

Q34726469-297DEB7C-397C-49F2-A111-407D5CAE344A

P6179

Q34726469-7F95E534-3015-4509-92CB-CC30F10ECB79

P698

Q34726469-226199D3-07BB-4CDB-9DEB-68DDC980BB77

P921

Q34726469-9EEAF5C2-D2F7-4B0F-A01E-F91AFAB5ED40

P932

Q34726469-4F7AFC25-5863-462D-BD29-2EEB256D8BEA

P356

S13300-014-0091-X

P1433

Diabetes Therapy

P1476

A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.

@en

P2093

Edward Wang

http://www.w3.org/2001/XMLSchema#string

George Dailey

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

Efficacy of intensive control of glucose in stroke prevention: a meta-analysis of data from 59,197 participants in 9 randomized controlled trials

Glycemic control and cardiovascular disease: what's a doctor to do?

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

10-year follow-up of intensive glucose control in type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Standards of medical care in diabetes--2013

P2888

s13300-014-0091-x

P304

385-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13300-014-0091-X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269773396

http://www.w3.org/2001/XMLSchema#string

P6179

1050527184

http://www.w3.org/2001/XMLSchema#string

P698

25515096

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4269651

http://www.w3.org/2001/XMLSchema#string